EMA Withdrawn: Invirase (saquinavir) — Roche Registration GmbH

View source ↗

Summary

The EMA withdrew Invirase (saquinavir) from registration in the EU, with Roche Registration GmbH as the MAH, in March 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Invirase (saquinavir)

Snippet

Status: Withdrawn. Therapeutic area: HIV Infections. MAH: Roche Registration GmbH. Decision date: 10/03/2023